Histoplasma capsulatum Complement Fixation and Immunodiffusion Assay Sensitivity in Culture-Confirmed Cases of Histoplasmosis: a 10-Year Retrospective Review (2011 to 2020)-Reference-Cited by-同舟云学术

Histoplasma capsulatum Complement Fixation and Immunodiffusion Assay Sensitivity in Culture-Confirmed Cases of Histoplasmosis: a 10-Year Retrospective Review (2011 to 2020)

Published:2022-10-19 Issue:10 Volume:60 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Fida Madiha¹,Misra Anisha²,Harring Julie A.²,Kubbara Aahd³,Theel Elitza S.²^ORCID

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA

2. Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA

3. Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA

Abstract

The detection of antibodies against Histoplasma capsulatum remains a frequently relied-on approach to diagnose histoplasmosis. We retrospectively assessed the performances of complement fixation (CF) and immunodiffusion (ID) assays for anti- Histoplasma antibody detection in patients with culture-confirmed histoplasmosis at Mayo Clinic (Rochester, MN) over a 10-year period (2011 to 2020).

Funder

Mayo Clinic

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/jcm.01057-22

Reference27 articles.

1. Diagnosis of histoplasmosis in immunosuppressed patients

2. Laboratory Diagnostics for Histoplasmosis

3. PCR Assay for Identification of Histoplasma capsulatum Based on the Nucleotide Sequence of the M Antigen